帕金森病的缺氧途径:从致病源到治疗点
Yuanyuan Gao1, Jiarui Zhang1, Tuoxian Tang2
1National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
International journal of molecular sciences
|October 16, 2024
概括
大脑缺氧或缺氧与帕金森病 (PD) 症状有关. 本综述探讨了缺氧和PD之间的分子联系,强调缺氧途径作为这种神经退行性疾病的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 病理生理学 病理生理学
- 分子生物学分子生物学
背景情况:
- 大脑的高氧需求使其易受缺氧的影响.
- 缺氧可能由各种疾病引起,包括血流受损和呼吸系统问题.
- 严重的脑缺氧与帕金森病 (PD) 有共同的症状.
研究的目的:
- 为了研究低氧和PD之间的分子相互作用.
- 强调缺氧通路在PD病变发生过程中的病理作用.
- 探索针对PD治疗的低氧途径的潜力.
主要方法:
- 对低氧和PD研究的文献综述.
- 对低氧和神经退行症相关的分子机制的分析.
- 检查PD发展中缺氧途径的证据.
主要成果:
- 缺氧及其相关途径与PD发展密切相关.
- 确定了低氧压力和PD病理学之间的特定分子相互作用.
- 有证据表明缺氧在帕金森病的进展中起着重要作用.
结论:
- 缺氧是帕金森病发病的一个关键因素.
- 准缺氧通路为PD提供了一个有前途的治疗策略.
- 对缺氧-PD分子联系的进一步研究是有效的治疗开发的必要条件.
相关概念视频
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Parkinson's Disease: Treatment
231
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
231
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
180
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
180
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
489
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
489
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


